This week: Be The Match BioTherapies® (MN, USA) and NantKwest (CA, USA) collaborate to help progress a potential cell therapy for COVID-19-associated ARDS and a new platform from WuXi Advanced Therapies (PA, USA) may help accelerate cell and gene therapy development.
ECommunity, Future Science Group
Comments are closed.